Von Willebrand disease primary prevention: Difference between revisions
Jump to navigation
Jump to search
Prince Djan (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Von Willebrand disease}} | {{Von Willebrand disease}} | ||
{{CMG}} {{PTD}} | |||
==Overview== | ==Overview== | ||
There are no known preventive measures for von Willebrand disease. In families with type 3 disease, genetic analysis may be useful for counseling. | |||
==Prevention== | ==Prevention== | ||
*There are no known preventive measures for von Willebrand disease. | *There are no known preventive measures for von Willebrand disease. | ||
*Avoidance of high-risk behaviors or situations may help prevent the development of bleeding. | |||
*In families with type 3 disease, genetic analysis may be useful for counseling.<ref name="pmid26245874">{{cite journal |vauthors=Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F |title=Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm |journal=Thromb. Haemost. |volume=115 |issue=1 |pages=40–50 |year=2016 |pmid=26245874 |doi=10.1160/TH15-04-0282 |url=}}</ref> | *In families with type 3 disease, genetic analysis may be useful for counseling.<ref name="pmid26245874">{{cite journal |vauthors=Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F |title=Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm |journal=Thromb. Haemost. |volume=115 |issue=1 |pages=40–50 |year=2016 |pmid=26245874 |doi=10.1160/TH15-04-0282 |url=}}</ref> | ||
Latest revision as of 00:06, 21 December 2018
|
Von Willebrand disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Von Willebrand disease primary prevention On the Web |
|
American Roentgen Ray Society Images of Von Willebrand disease primary prevention |
|
Risk calculators and risk factors for Von Willebrand disease primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Prince Tano Djan, BSc, MBChB [2]
Overview
There are no known preventive measures for von Willebrand disease. In families with type 3 disease, genetic analysis may be useful for counseling.
Prevention
- There are no known preventive measures for von Willebrand disease.
- Avoidance of high-risk behaviors or situations may help prevent the development of bleeding.
- In families with type 3 disease, genetic analysis may be useful for counseling.[1]
References
- ↑ Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F (2016). "Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm". Thromb. Haemost. 115 (1): 40–50. doi:10.1160/TH15-04-0282. PMID 26245874.